ACTIVIN-ACTRII ANTAGONISTS AND USES FOR TREATING MYELODYSPLASTIC SYNDROME
Publication
EP4233889A2
Kind: A2
Mar 18, 2026
Applicants
Celgene Corporation, Acceleron Pharma Inc.
Inventors
ATTIE, Kenneth M., ROVALDI, Christopher, LAADEM, Abderrahmane
IPC Classifications
A61K 38/17 20060101AFI20230906BHEP
C07K 14/71 20060101ALI20230906BHEP
G01N 33/49 20060101ALI20230906BHEP
A61P 7/00 20060101ALI20230906BHEP
A61P 7/06 20060101ALI20230906BHEP
A61P 35/02 20060101ALI20230906BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR